The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?

Detalles Bibliográficos
Autores principales: Cohn, David E., Shimp, William S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563795/
https://www.ncbi.nlm.nih.gov/pubmed/26425721
http://dx.doi.org/10.1016/j.gore.2015.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563795/
https://www.ncbi.nlm.nih.gov/pubmed/26425721
http://dx.doi.org/10.1016/j.gore.2015.06.009

Ejemplares similares